Onyx ONE trial: a new option in patients at high risk of bleeding
INTRODUCTION Due to the commotion caused by the growing number of late thrombosis after drug-eluting stents implantation back in 2005,1 1 year courses of dual antiplatelet therapy (DAPT) were recommended after the implants. The lower rate of this complication thanks to improved designs of the device...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2020-02-01
|
| Series: | REC: Interventional Cardiology (English Ed.) |
| Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=266 |